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In new generation medical therapies for type 1 diabetes mellitus (DM), cell-based approaches using pancreatic 
islets have attracted significant attention worldwide. In particular, dispersed islet cells obtained from isolated 
pancreatic islets have been a valuable source in the cell biology and tissue engineering fields. Our experimental 
approach to the development of new islet-based DM therapies consisted of creating a monolithic islet cell sheet 
format using dispersed islet cells. In this experiment, we explored the potential of internationally transporting 
human islets from Alberta, Canada to Tokyo, Japan and obtaining viable dispersed islet cells. A total of 34 
batches of isolated and purified human islets were transported using a commercial air courier service. Prior 
to shipping, the human islets had been in culture for 0–108 h at the University of Alberta. The transportation 
period from Alberta to Tokyo was 2–5 days. The transported human islet cells were enzymatically dispersed as 
single cells in Tokyo. The number of single islet cells decreased as the number of transportation days increased. 
In contrast, cell viability was maintained regardless of the number of transportation days. The preshipment 
culture time had no effect on the number or viability of single cells dispersed in Tokyo. When dispersed single 
islet cells were plated on laminin-5-coated temperature-responsive polymer-grafted culture dishes, the cells 
showed favorable attachment followed by extension as a monolithic format. The present study demonstrated 
that long-distance transported human islets are a viable cell source for experiments utilizing dispersed human 
islet cells.
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INTRODUCTION
As researchers continue to discover that human islets 
differ in several critical biological ways from nonhuman 
islets, continuing experimental research using human 
islets is anticipated (9). To meet this increasing demand 
for human islets, several attempts have been made to dis-
tribute isolated human islets nationally and internation-
ally (8,9,12,19). To this end, the Clinical Islet Laboratory 
at the University of Alberta initiated its own human islet 
distribution program in 2007 to increase the opportunities 
for researchers to conduct these studies in remote loca-
tions (11). Transported human islets have been proven to 
be valuable and have contributed to the continued prog-
ress of islet-based basic research (16,17,27,29).
Cell-based therapy using pancreatic islets has been 
established as a promising new therapy for patients with 
type 1 diabetes mellitus (DM). To enhance the success of 
islet-based therapies, the establishment of new approaches 
incorporating novel technologies that prolong transplanted 
islet cell longevity is vital. Accordingly, the use of dispersed 
single islet cells has been described as a viable approach to 
creating functional islet tissues (14,25,26). In particular, our 
laboratory has successfully fabricated a contiguous cell sheet 
format (islet cell sheet) in a culture condition using dispersed 
islet cells (25,26). This technology is based on culturing 
dispersed islet cells on a temperature-responsive polymer-
grafted culture dish followed by temperature-dependent, 
nonchemical cell harvesting (32). Transplanting the islet cell 
sheets into a subcutaneous space resulted in the creation of 
neoislet tissues. The engineered neoislet tissues were found 
to provide therapeutic value by normalizing blood glucose 
levels in mice with DM (24). To use islet cell sheets as a 
clinical treatment for DM, human islet cell sheets made of 
dispersed islet cells must first be created. To date, investiga-
tions of the quality and values of dispersed single islet cells 
obtained over long distances have not been addressed.
In this study, we internationally transported 34 batches 
of human islet cells from the University of Alberta, Canada 
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to Tokyo Women’s Medical University, Japan via a com-
mercial air courier service. We obtained dispersed islet 
cells from the transported human islets and investigated 
the effects of the transportation period and the preship-
ment culture time on the cell quantity and quality. We also 
assessed the biological viability of the obtained dispersed 
islet cells by culturing the cells on culture surfaces specifi-
cally designed by our group for islet cell culturing (26).
MATERIALS AND METHODS
Human Islets
Thirty-four human islet preparations from deceased 
donors that failed to meet defined release criteria for clini-
cal transplantation were used in this study. Written con-
sent for research was provided by donor relatives in all 34 
cases. The study further obtained ethical approval from the 
human Research Ethics Board of the University of Alberta 
and Tokyo Women’s Medical University. Islets were 
cultured in Connaught Medical Research Laboratories 
(CMRL) 1066 medium (Mediatech, herndon, VA, USA) 
at 22°C until they were transported. Mean age of the 34 
donors was 49 ± 12 (range 16–70) years, and 14 were male 
and 20 were female. The viability (%) of islets before 
shipping was measured by using SYTO Green (Life 
Technologies, Carlsbad, CA, USA) and ethidium bromide 
(Sigma, St. Louis, MO, USA) dyes.
Transportation
human islets resuspended in CMRL 1066 medium 
in a 50-ml conical tube (BD Biosciences, San Jose, CA, 
USA) were shipped from Edmonton to Tokyo by a com-
mercial air courier. The cargo space in the aircraft was set 
at 15–17°C.
Dispersed Islet in Tokyo
Transported islets were subsequently cultured in 
Roswell Park Memorial Institute (RPMI) 1640 medium 
(Sigma) containing 10% fetal bovine serum (FBS; Thermo 
Fisher Scientific, Waltham, MA, USA) and 5.5 mM glu-
cose (Otsuka Pharmaceutical, Tokyo, Japan) overnight. 
On the following day, islets were incubated with 0.125% 
trypsin–EDTA (Life Technologies) at 37°C for 3 min and 
dispersed by a 20-time pipetting for 30 s, followed by 
trypsin inactivation by addition of 10% FBS. Finally, the 
suspension of dispersed single islet cells was obtained by 
filtering through a 70-µm cell strainer (BD Biosciences).
Assessments of the Dispersed Single Islet Cells in Tokyo
The number and the viability (%) of single dispersed 
islet cells were determined by counting with trypan blue 
(Life Technologies) exclusion test. The effects of trans-
portation time from Canada to Tokyo and preshipment 
culture time at Canada on the number and viability of 
cells were investigated. Transport time was split into two 
groups: 2 days (n = 26) and greater than 2 days (n = 8). In 
the latter experiment, islet batches transported with the 
shortest transportation days (2 days) were analyzed. Cell 
recovery was expressed by the actual number of dispersed 
islet cells per volume of islet (packed cell volume) before 
shipment (×107 cells/ml).
Islet Cell Culturing on Temperature-Responsive 
Culture Dishes
Culture surfaces specifically designed for dispersed islet 
cell culturing were prepared by coating rat laminin-5 in 
phosphate-buffered saline (PBS) (0.21 mg/cm2; Chemi-
con International, Temecula, CA, USA) on temperature-
responsive polymer [poly(N-isopropylacrylamide); 
PIPAAm]-grafted culture dishes (UpCell, CellSeed, 
Tokyo, Japan) as described previously (25,26). PBS was 
used as noncoated control. Dispersed human islet cells 
resuspended with RPMI 1640 medium containing 10% 
FBS were plated at a density of 1.3 × 105 cells/cm2 and cul-
tured at 37°C. Twenty-four hours later, the culture dishes 
were washed to remove the nonattached cells and replen-
ished with RPMI 1640 containing 10% FBS.
Measurement of Cell Attachment and Confluency Rates
To quantify the cell attachment rate of dispersed human 
islet cells to noncoated and laminin-5-coated PIPAAm-
grafted dishes, the number of viable cells was assessed 
using a water-soluble tetrazolium salt (WST) method with 
a Cell Counting Kit-8 (Dojindo Laboratory, Kumamoto, 
Japan) on day 1 (24 h after cell seeding) after the unat-
tached cells were washed away (n = 4 per each group). On 
day 3 (72 h after the cell seeding), we calculated the islet 
cell confluency, which was expressed as the percentage of 
the total surface of attached cells per culture surface area 
(n = 4 for each group).
Insulin Secretion Assay
On day 3, the insulin secretion assay was conducted 
as described previously. In brief, the culture medium 
was changed with fresh RPMI medium containing 
3.3 mmol/L glucose and cultured for 180 min. After 
this incubation step, the medium was then replaced 
with RPMI medium containing 3.3 mmol/L glucose for 
60 min and then replaced with RPMI with 20 mmol/L 
glucose for 60 min. For the final step, the medium was 
replaced with RPMI medium containing 3.3 mmol/L 
glucose for 60 min. At the end of each time point, the 
culture medium was collected and kept frozen at −20°C 
until analysis. The amount of secreted insulin in the cul-
ture medium (n = 3 per time point) was measured using 
an Ultra Sensitive human Insulin ELISA Kit (Morinaga 
Institute of Biological Science, Kanagawa, Japan). The 
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data allowed an insulin stimulation index (SI) to be cal-
culated using the following equation: SI = (insulin con-
tent in the 20 mmol/L glucose medium)/(insulin content 
in the initial 3.3 mmol/L glucose medium).
Statistical Analyses
All values are expressed as mean ± standard deviation 
(SD). Student’s t test was used to compare data between 
two groups. The significance of differences among three 
or more groups was tested by one-way ANOVA, followed 
by Scheffe’s least significant difference post hoc analysis 
(PASW Statistics 18 software, IBM Japan, Tokyo, Japan). 
The probability less than 0.05 was considered to be statis-
tically significant.
RESULTS
Quality and Quantity of Dispersed Islet Cells in Tokyo
The viability of islets at Canada before shipping was 
81.3 ± 8.1%. After transportation, the number and viabil-
ity of dispersed islet cells were 6.4 ± 4.7 × 107 per batch 
and 75.6 ± 12.8%, respectively. 
Effect of Transportation Time on the Quantity and 
Quality of Dispersed Islet Cells in Tokyo
The transportation time from Alberta to Tokyo was 
between 2 and 5 days. The number of dispersed islet cells 
obtained in Tokyo decreased with increasing transporta-
tion time (Fig. 1). The number of cells in the 2-day group 
(n = 26) showed significantly higher values compared with 
that of more than 2-day group (n = 8). The cell viability of 
2-day and more than 2-day groups was 77.2 ± 12.2% and 
72.8 ± 14.2%, respectively (p = 0.40).
Effect of Preshipment Culture Time on the Quantity and 
Quality of Dispersed Islet Cells in Tokyo
Transported islets in the 2-day transportation were 
assessed among groups stratified by preshipment culture 
time (<25 h, 25–48 h, 49–72 h, and >72 h). No significant 
differences among groups were observed in both quantity 
and quality of the dispersed islet cells (Fig. 2). 
Dispersed Islet Cell Culture
To investigate whether dispersed single islets obtained 
from transported human islets could be used for mono-
layer culturing, cells were plated on laminin-5-coated 
PIPAAm dishes. The cells showed significantly higher 
attachment ratio at day 1 on the coated versus noncoated 
dishes (Fig. 3A). The cells on the laminin-5-coated 
PIPAAm dishes subsequently showed stable attachment 
and cellular extension and reached near confluency on 
day 3 (Fig. 3B–D). The biological functionality of the 
cultured human islet cells was determined by their ability 
to increase the secretion of insulin in response to increas-
ing doses of glucose into the medium. Five of five differ-
ent lots of human dispersed islet cells showed a positive 
stimulation index (SI > 1) when the cells were cultured 
on laminin-5-coated PIPAAm dishes. In contrast, only 
one of five cell lots showed a positive SI when the cells 
Figure 1. Effect of transportation time on the number of dispersed islet cells obtained from transported islets in Tokyo. The trans-
ported human islets were cultured overnight, followed by digestion for obtaining single dispersed islet cells. The transportation time 
was 2 days (n = 26), 3 days (n = 4), 4 days (n = 2), or 5 days (n = 2). Cell recovery was expressed by the obtained number of dispersed 
islet cells per volume of islet (packed cell volume) before shipment (×107 cells/ml). *p < 0.05 between 2-day group and a combined 
“more than 2-day” group (n = 8) by Student’s t test. 
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were cultured on noncoated PIPAAm surfaces. SIs were 
1.7 ± 0.6 and 1.0 ± 1.1, in the laminin-5-coated and non-
coated groups, respectively (n = 5 for each group).
DISCUSSION AND CONCLUSION
The present study explored 34 international long-
distance transportations of human islets for the use of 
dispersed islet cells. The recovery rate of dispersed islet 
cells was clearly higher in the shorter transportation time 
group, whereas cell viability was not associated with 
trans portation time. The preshipment culture time had no 
negative impact on cell quantity or quality. The dispersed 
single islet cells favorably attached to the laminin-5-
coated PIPAAm dishes and retained their intrinsic ability 
to secrete insulin in a glucose-dependent manner.
To provide the higher chance of islet transplantation to 
the patients, Langer et al. (15) initiated international islet 
shipping to allow patients in other countries to receive 
islet cell transplantation. To maximize the success of inter-
national islet distribution, several islet shipping proce-
dure refinements have been made, including the use of a 
gas permeable bag (2,7) and encapsulating the islets (30). 
In our study, the shipments were conducted in a simpler 
system in which the islets were resuspended in regu-
lar culture medium and packed in 50-ml conical tubes. 
Although the number of dispersed islet cells decreased as 
transportation time increased (≥3 days), 2-day transporta-
tion resulted in a sufficient number of cells. Furthermore, 
cell viability was maintained regardless of transportation 
time. These data demonstrated that dispersed islet cells 
obtained from long-distance transported human islets were 
valuable for use in basic medical research even at longer 
transportation distances. 
Several studies had addressed the effect of preship-
ment culture on transported islet quality (13). Ichii et al. 
(6) reported that preshipment islet culturing minimally 
affects islet viability but that culturing results lower yield. 
Culturing before transplantation is known to be related 
with islet loss (13). A previous investigation by Kin et al. 
(13) provided evidence that islet culture period (median, 
20 h; 16–30 h) is associated with the increase of morphol-
ogy score and islet viability without affecting islet purity. 
The present study showed that preshipment culture period 
minimally affected cell number and viability assessed 
after the transportation. 
In our islet transportation process, human islets resus-
pended in 50-ml conical tubes were shipped from Alberta 
to Tokyo by a commercial air courier. This packing offered 
simple and easy carrying. Noguchi et al. (20) reported that 
low culture temperature prevented islet damage. Medications 
such as glucagon-like receptor inhibitor that can be used to 
prevent islet apoptosis have recently been reported (22). In 
the future, transportation temperature or culture medium 
may be modified to obtain better cell viability. 
The value of dispersed islet cells has been examined 
in different experimental conditions, including an assess-
ment platform for islet cell biological functions and cel-
lular signaling (4,5,10), cell proliferation analyses (23), 
and reforming cellular aggregates (pseudoislets) or hybrid 
islet tissue devices (14,31). One of our approaches to the 
Figure 2. Effect of preshipment culture time at the University of Alberta on the number of dispersed islet cells obtained from trans-
ported islets in Tokyo. Dispersed islet cell number and their cell viability obtained in Tokyo in the 2-day transportation group (n = 26) 
were determined according to the culture time conducted at the University of Alberta before the shipping. The preshipment culture 
time was less than 25 h (n = 7), 25–48 h (n = 6), 49–72 h (n = 8), or longer than 72 h (n = 5). Cell recovery was expressed by the obtained 
number of dispersed islet cells per volume of islet (packed cell volume) before shipment (×107 cells/ml). No statistical intergroup dif-
ferences were found in both cell recovery and viability by one-way ANOVA with multiple comparisons. The bars indicate cell recov-
ery, and the closed triangles () indicate cell viability.
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creation of functional islet tissues consists of bioengi-
neering monolayer islet cell sheets (21,25,26). An impor-
tant feature of this approach is the preparation of culture 
surfaces specifically defined for islet cell culturing; that 
is, rat laminin-5-coated PIPAAm surfaces. Laminin-5 is 
known to contribute to b-cell proliferation, b-cell apopto-
sis protection, and insulin secretion (1,3,25). The present 
study showed that rat laminin-5 resulted in significant cel-
lular attachment of dispersed human islet cells followed 
by biological functionality expression in terms of glu-
cose-stimulated insulin secretion. Regardless, the present 
study established that biologically functional dispersed 
human islet cells could be obtained from isolated islet 
batches that had been transported over long distances.
The present study underscores the value of transported 
human islets as a cell source for research using dispersed 
islet cells. Since ductal and exocrine cells exist in islet 
batches isolated for clinical transplantation purposes 
(28), the investigation of cell composition in dispersed 
islet cells from transported human islets is important for 
maximizing the investigational potential of using cells 
dispersed from isolated islet batches. Regardless, this 
study highlighted the value of human islets transported 
over long distances by a commercial air courier service 
to supply dispersed islet cells. Further studies utilizing 
dispersed islet cells are highly anticipated.
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